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Well-known aminaacyl-tRNA synthetase (ARSase) inhibitors, namely the analogues of amino acids and aminoacyl adenylates (atninoalkyl- and 
aminophosphonyl adenylates with K, ~0.1 ,uM) as well as the diadenosine 5’,5”‘-pi,@-tetraphospbate (Ap&A) phosphonoanalogues, were for the 
first time used for the Ap,A biosynthesis regulation. Effects of a set of such compounds on lysyl-, phenylalanyl- and alanyl-tRNA synthetases 
from E. coli, capable of synthesizing Ap,A in the presence of Zn2’ ions and pyrophosphatase, have been studied. The adenylate analogues were 
found to inhibit the Ap,A and Ap,A formation (I,, ~6 mM). Aminophasphonic and aminophosphonous acids are not involved in Ap,A and Ap+A 
biosynthesis and inhibited it at high concentrations. The Ap,A phospboanalogues slightly inhibited the major reactions of ARSases, as well as 
the biosynthesis ofA&A and Ap,A, at a concentration of 5 mM. 
Ap,A syntltesis; ~noa~yl-tRNA synthetase; Aminoalkyl adenylate; Aminopho~honyl adenylate; Aminophosphoni~ acid; 
A~no~hosphonous acid; Ap+A phosphonoanal~gue 
1. INTRODUCTION 
Dinucleoside oligophosphates, in particular, ApdA, 
are involved in metabolic processes such as cell pro- 
liferation and DNA replication (for review see [I]), 
RNA processing [2), blood clotting [3], heat shock and 
oxidative stress [4], and the transformation of purine 
nucleotides f5] _ 
ApaA can be synthesized by various aminoacyl-tRNA 
synthetases [6-8] under certain conditions which differ 
noticeably from those involved in normal aminaacyia- 
tion. Apparently, an intermediate aminoacyl adenylate 
interacts with ATP because the synthesis occurs in the 
presence of a substrate amino acid. 
The inhibition of enzyme-catalyzed Ap4A formation 
could be a possible way to regulate the level of Ap4A in 
the cell. However, the possibility of inhibition of this 
reaction, particularly through the use of specific in- 
hibitors for ARSases, has not been adequately studied, 
although the peculiarities of ApdA enzyme-catalysed 
synthesis have been discussed in detail [G-g]. The pre- 
sent work demonstrates that the known inhibitors of 
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ARSases, namely, phosphoanalogues of substrate 
amino acids (Ia-f) and aminoacyl adenylates (I&b; 
IIIa,b) as well as Ap4A phosphonate analagues 
(IVa-d), can inhibit, in a weak or nonspecific manner, 
enzymatic synthesis of diadenosine oligophosphates 
catalysed by lysyl-, phenylatanyl- and alanyl-tRNA syn- 
thetases from Exoii. 
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2. MATERIALS AND METHODS 
2.1. Chemical compounds 
Phosphorus-containing analogues of amino acids and aminoacyi 
adenylates were prepared as described elsewhere [9,1fJ~.Aminoalkyl 
adenylates were synthesized as in [I if. ApeA phosphonate analogues 
were prepared as described in [12,133. Ap4A and ApsA were from P.- 
I.,. B&hem. &l-r4C]ATP (507 Ci/moI) was purchased from Amer- 
sham. 
2.2. Enzymes and their acfivify assay 
Homogeneous E. cofi MRE-600 phenyblanyl-tRNA synthetase was 
prepared as in [14]. E. coli B lysyl- and alanyl-tRNA synthetases were 
purified to a homogeneity of 70 and 75%, respectively, as in [15,16]. 
E. coli B tRNALyS and tRNAMUa were purified according to [18]. E. 
calf MRE-600 tRNAPhe was prepared as described elsewhere 1171. The 
activity of ARSases was assayed using a standard procedure in the 
reactions of isotope [32P]PPi-ATP exchange and tRNA aminoacyla- 
tion as in 1191. The enzyme-catalysed synthesis of Ap3A and Ap.+A 
was determined as described earlier 171. The radioactivity of TLC 
plates was determined by express analysis using a set of ~ns~ments 
including a counter. a computer, a display or a plotter as described in 
[ZOJ. Yeast inorganic p~oph~phat~e was obtained from P.-L. 
Biochem. (spec. act. 200 unitslmg at 25*C). 
3. RESULTS AND DISCUSSION 
The analogues of aminoacyl adenylates, intermediate 
compounds in the enzyme-catalysed reaction, are the 
most active and specific inhibitors of ARSases [ 10,111. 
Since aminoacyl adenylates are presumed to be formed 
as intermediate compounds in the biosynthesis of dia- 
denosine oligophosphates~ these inhibitors also shoufd 
be expected to have strongly suppressed Ap4A syn- 
thesis. However, both AMP aminoalkyl esters (HI) and 
aminophosphonyl adenylates (If) turned out to be weak 
and nonspecific inhibitors of Ap4A and Ap3A synthesis 
which had been catalysed by ARSases used in the ex- 
periments. As can be seen in Fig, 1, for phenylalanyl- 
tRNA synthetase, phenylalaninol-AMP (IIIa), amino- 
ethylphosphonyl adenylate (II@, aminophenylethyl- 
phosphonyl adenylate (IIb) and lysinol-AMP (IIIb) in 
an identically weak manner inhibit Ap3A and Ap4A 
synthesis at a 1 mM concentration. Nevertheless, in the 
normal reaction of tRNAPhe e~yme-catalysed 
aminoacylation, the compounds (IIIa) and frrb) selec- 
tivity inhibit the synthetase activity with the Ki = IO-’ 
0 3 6 9 
(inhibitor), mM 
Fig. 1. Inhibition by adenylates (IIa,b), (IIIa,b), phosphorus- 
containing L-phenylalanine analogues (Ie,d) and a phosphonate 
Ap4A analogue (IVb) of Ap4A and ApsA synthesis catalysed by E. 
coli MRE-0 phenylalanyl-tRNA synthetase. The reaction mixture 
had the same composition as indicated in [20]. 5 $ aliquots of the 
reaction mixture were applied to plates every 30 min and, after TLC, 
were anatysed as described in section 2 (0) (S.R.M.)=standard 
reaCtiOn mixture without ~nhibi~rs; ( V) (Ha); ( I3 ) (Hb); (lg ) (Ifia); 
(0) (IIWb); (a) (W; (A) (Id); (a) (IVb). 
M, whereas compounds (IIa) and (IIIb) whose structure 
is quite different from that of phenylalanyl adenylate, 
inhibit ,it with Ki 2: 10m3 M. Similar results have been 
obtained for other ARSases. These data are indicative 
of fundamental differences between the normal reac- 
tion of tRNA amino-acylation and Ap4A synthesis in 
the intermediate steps of the enzyme-catalysed reaction. 
It is known that aminophosphomc acids (Ia,c,e) are 
not substrates in the overall reaction and, with the ex- 
ception of l-amino-2-PhenyI~hyIph~spho~c a id (1~)~ 
show a low affinity for synthetases. In contrast, ty- 
aminophosphonous acids* (Ib,d,f) have an elevated af- 
finity for these enzymes, as a rule, close to that of a 
substrate amino acid. Some of them, in particular, LY- 
aminoisobutylphosphonous and a-amino-y-methyl- 
thiopropylphosphonous acids, can substitute for valine 
and methionine in the reactions of ATP-PPi exchange 
which have been catalysed by the corresponding 
ARSases [21]. However, aminophosphonous and 
aminophosphonic acids cannot substitute for substrate 
amino acids in ApeA synthesis and virtually do not in- 
hibit the reaction at a 10-’ M concentration or more. 
In contrast to AMP aminoalkyl esters (III), 
~inophosphonyl adenylates (II) contain an active 
anhydride bond which, in principle, makes an enzyme- 
catalysed reaction of (II) with ATP and the formation 
of Ap4A possible. Nevertheless, none of the synthetases 
that have been studied, including alanyl-tRNA syn- 
the&se (Fig. 2), catalyses this process, just a compound 
(II) does not react with PPi in the normal synthetase 
reaction [ 191. 
*In the present paper we used the trivial name ‘a~noph~phonous 
acid’ instead of l ~~ophophini~ acid’ that was recommended by the 
IUPAC Nomenclature of Organic Chemistry. 
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Fig. 2. Express analysis of labeled nucleotides from the reaction 
mixture for Ap4A and ApsA synthesis catalysed by E. coli B alanyl- 
tRNA synthetase after TLC on PEI-cellulose plates (see section 2). 
Figure of a plotter indicating relative radioactivity distribution in 
nucleotide spots on the chromatogram after the reaction mixture was 
incubated at 37°C for 180 min. Relative nucleotide mobility 
corresponded to that indicated in [23]. (S.R.M.)‘-‘= standard 
reaction mixture without L&mine. (A) (S.R.M.); B: (S.R.M.)‘-‘+ 2 
mM (Ia) or 2 mM (Lb); C: (S.R.M.)‘-‘+2 mM (Ha); D: 
(S.R.M.)(-)+ 6 mM (IVb). ATP, ADP, AMP, (Ha) and (IVb) (2 mM 
each in 50 mM Tris-HCl, pH 7.8 + 10 mM MgCh) were applied to the 
plate margins as a standard. 
So far, the effect of Ap4A was studied only with rat 
liver lysyl-tRNA synthetase [22] where Ap4A acted as a 
competitive (with respect o ATP) inhibitor of tRNALyS 
aminoacylation with the Ki=2.5 pM. We found a 
similar situation with alanyl-tRNA synthetase although 
the Ki was greater by two orders of magnitude (0.4 
mM). In the case of other studied ARSases, we found 
that Ap4A and its metabolically stable analogues, in 
which the O-atoms between the phosphorous atoms 1 
and 2 or 2 and 3 were substituted by CH2 or CHBr 
groups, did not compete with ATP for the sites of bind- 
10 
8 
6 
4 
2 
0014 
[ I/ATP )x 10-4( M ) 
Fig. 3. Inhibition of lysyl-tRNALYs ynthesis by Ap4A. tRNALyS was 
aminoacylated at saturating concentrations of tRNA (40 FM) and L- 
lysine (30 PM with sp. act. 240 Ci/mol) and different ATP 
concentrations. Ap.+A concentrations: (0) = 0 mM; (0) = 3 mM. 
ing on the enzyme (Fig. 3) and weakly inhibited the 
main reaction. Moreover, those compounds used at a 3 
mM concentration weakly inhibited the synthesis of 
ApdA, which indicated that this reaction in general was 
not prone to chemical regulation. 
It would be relevant o note that the Ap4A analogues 
used in this work are potent inhibitors (the Ki = 0.1-5 
FM) of some ApdA-phosphohydrolases [23]. Therefore, 
stable Ap4A analogues can be used for studying the 
function of Ap4A in the cell since they weakly affect the 
synthesis of ApdA, but prevent its degradation in 
catabolic processes. 
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